Arthritis & Rheumatism · 2001 · 64 citations · 56 references
MedicineMedicinal ChemistryPharmacologyCell SignalingImmunopathologyInflammationAnti-inflammatory PharmacologyCytokine BiologyCytokine SignalingInflammatory Cell SignalingInflammatory MediatorsInflammatory SignalingAnti-inflammatory MechanismsAnti-inflammatory TherapeuticsCollagen Matrix DegradationCytokine-mediated Tissue BreakdownDegradationInflammatory Mediators In CartilageMatrix MetalloproteinasesMessenger Rna Transcription
OBJECTIVE: To address the effects of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO), on the induction of matrix metalloproteinases 1 and 13 (MMP-1, MMP-13) by inflammatory cytokines. METHODS: Human chondrosarcoma cells stimulated with inflammatory cytokines (interleukin-1beta [IL-1beta], tumor necrosis factor alpha) were used to study the effects of CDDO on the induction of MMPs and the invasion of cells through a collagen matrix. RESULTS: CDDO selectively reduced the induction of MMP-1 and MMP-13 at the levels of messenger RNA and protein. Treatment with CDDO prior to cytokine stimulation enhanced this inhibition, and we demonstrated that CDDO functions at the level of transcription. Additionally, CDDO reduced IL-1beta-mediated invasion of cells through a collagen matrix. CONCLUSION: This study demonstrates that CDDO is a novel inhibitor of MMP-1 and MMP-13 gene expression mediated by inflammatory cytokines. Thus, CDDO may have therapeutic potential for the inhibition of joint degradation in osteoarthritis.
56
Biologic basis for interleukin-1 in disease
CA Dinarello · Blood · 1996 · 4.4K citations · Full text
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Mercedes Ricote, Andrew C. Li, Timothy M. Willson et al. · Nature · 1998 · 3.5K citations
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Chengyu Jiang, Adrian T. Ting, Brian Seed · Nature · 1998 · 2.9K citations